arrow
P

Peter Bramlage

Institute for Pharmacology and Preventive Medicine
H指数:51
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TCT-1221 ReTAVI Registry: Early Outcomes of Redo-TAVI with SAPIEN Platform in a Real-World Prospective Cohort

TCT-1221 ReTAVI 注册研究:真实世界前瞻性队列中采用 SAPIEN 平台进行二次 TAVI 的早期结果

JACC
IF0
2025-10-220
PRE
Gender-based outcomes following surgical aortic valve replacement: a multicentre propensity score matching analysis
2025-07-010
PRE
Gender differences in the presentation and management of patients with severe aortic stenosis at specialist versus primary/secondary care centres: A sub-analysis of the IMPULSE enhanced registry

在专科中心与初级/次级保健中心,严重主动脉瓣狭窄患者临床表现与管理的性别差异:IMPULSE增强型登记研究的亚组分析

2025-07-011
PRE
Treatment of Venous Thromboembolism with Edoxaban over 18 Months: Results from ETNA-VTE Europe

Edoxaban治疗静脉血栓栓塞超过18个月: 来自etna-vte Europe的结果

2025-01-160
OAAI
Impact of Physical Activity in Patients With Atrial Fibrillation Undergoing Catheter Ablation: The Multicenter Randomized BE-ACTION Trial

体力活动对接受导管消融的房颤患者的影响: 多中心随机BE-ACTION试验

2024-10-012
PRE
Impact of telemedical management on hospitalization and mortality in heart failure patients with diabetes: a post-hoc subgroup analysis of the TIM-HF2 trial
2024-06-121
OAAI
A streamlined pathway for transcatheter aortic valve implantation: the BENCHMARK study
2024-03-305
OAAI